Medical AI Alliance
Company Index
Pharma & CDMOKOSDAQ 4604702 approvals

IVIM Technology, Inc.

Official website

IVIM Technology provides all-in-one intravital microscopes and CRO imaging-analysis services for live-animal organ and tissue research.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2017, IVIM Technology listed on KOSDAQ in 2024 as an intravital microscopy company. It offers an all-in-one intravital microscope lineup including confocal microscopes IVM-C, C2, and C3, confocal two-photon microscopes IVM-CM, CM2, and CM3, and two-photon microscopes IVM-MS, MS2, MS3, M2, and M3, along with the IVM-TMS tissue motion stabilizer that reduces tissue movement during imaging. It also provides organ-specific Imaging Window/Chamber kits for the heart, lung, cranium, abdomen, and mammary gland, and runs a one-stop CRO service covering everything from cell-level imaging in live animal models to drug pharmacokinetics analysis.

Products & technology

  • IVM-C/C2/C31st-3rd generation confocal intravital microscope
  • IVM-CM/CM2/CM31st-3rd generation confocal two-photon intravital microscope
  • IVM-MS/MS2/MS31st-3rd generation two-photon intravital microscope (fixed wavelength)
  • IVM-M2/M32nd-3rd generation two-photon intravital microscope (tunable wavelength)
  • IVM-TMSTissue motion stabilizer imaging accessory
  • CRO serviceCell-level imaging and drug pharmacokinetics analysis service using intravital microscopy in animal models
  • Imaging Window/Chamber Kits (Dorsal Skinfold, Heart, Lung, Cranial, Abdominal, Mammary)Organ/site-specific imaging accessories

Regulatory approvals

data.go.kr

2 Korean MFDS device approvals · 2021–2026

  • MFDSFluorescence imaging system2026-08-10
    Product approval · Class 2제인 26-4730 호
  • MFDSCell/histopathologic image processor2021-05-17
    Product approval · Class 1체외 제신 21-690 호
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Noul Co., Ltd.1 shared

Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.

Vieworks Co., Ltd.1 shared

Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition